2018 World Serialization Map6 April 2018
9. Rational Drug Use Provincial Coordinators Evaluation Meeting11 May 2018
Nowadays, we are consuming almost everything in organic ways. For us; healthy and longer living has become a priority. Even we take precautions or pay attention to this priority; daily stress, the radiation that we receive from electronic devices, fastfood consumption among young generation and most importantly smoking have an impact on increasing our risk for cancer.
During the “World Cancer Day”event, which was held on 4th February 2017, as a keynote speaker Prof. Dr. Füsun Tokatlı mentioned that, each year 17 million people have cancer on earth and 8 million of them die. In US the number of people who had cancer was 1.7 million. In Turkey this number was 160.000. Cancer is more common amongst men than women (almost %20).
On the other hand, according to the 2014 WHO report of death rates of cancer is 90.900 for Turkey. Also according to the report of Turkish Statistical Institute dated May 2017, 1 out of every 5 people lose their lives to cancer.
When we look to the volume of World Pharmaceutical Market, we can see that it has reached to 1.1 TN $ at the end of 2017. US is still the leader of the market and then China, Japan, Germany and France come. When we consider the subject that is mentioned above, we can obviously say that the use of oncological pharmaceuticals will increase. While oncological pharmaceuticals had %11.7 of World Pharmaceutical Market in 2016, it is expected to reach %17.5 in 2022 and as a sale volume it is predicted to reach double of current level between 2016 and 2022.
In this situation, the demand for oncological pharmaceuticals will extremely increase in Turkey. Before Turkey developed the Pharmaceutical Track&Trace System (İTS) patients had difficulties to find and buy oncological pharmaceuticals however, it became easier to see whether the pharmaceuticals are in stokcs and in which city, province and pharmacy with İTS. The Pharmaceutical Track&Trace System will play a crucial role in order to reach and track those pharmaceuticals in near future which oncological pharmaceuticals have a great impact on sales and share in the market.